143 related articles for article (PubMed ID: 20453401)
21. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
22. Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial.
Zheng Z; Zhang H; Peng X; Zhang C; Xing C; Xu G; Fu P; Ni Z; Chen J; Xu Z; Zhao MH; Li S; Huang X; Miao L; Chen X; Liu B; He Y; Li J; Liu L; Kadeerbai H; Liu Z; Liu Z
JAMA Netw Open; 2022 Mar; 5(3):e224492. PubMed ID: 35353167
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
Zavada J; Pesickova S; Rysava R; Olejarova M; Horák P; Hrncír Z; Rychlík I; Havrda M; Vítova J; Lukác J; Rovensky J; Tegzova D; Böhmova J; Zadrazil J; Hána J; Dostál C; Tesar V
Lupus; 2010 Oct; 19(11):1281-9. PubMed ID: 20605876
[TBL] [Abstract][Full Text] [Related]
25. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
28. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
Burchardi C; Schlöndorff D
Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
[No Abstract] [Full Text] [Related]
29. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.
Boletis JN; Ioannidis JP; Boki KA; Moutsopoulos HM
Lancet; 1999 Aug; 354(9178):569-70. PubMed ID: 10470708
[TBL] [Abstract][Full Text] [Related]
30. [A case of lupus nephritis resistant to steroid pulse therapy markedly improved by bolus intravenous cyclophosphamide therapy].
Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Kurata T; Arimori S
Ryumachi; 1989 Aug; 29(4):291-6. PubMed ID: 2617371
[TBL] [Abstract][Full Text] [Related]
31. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
[TBL] [Abstract][Full Text] [Related]
32. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy.
Barbano G; Gusmano R; Damasio B; Alpigiani MG; Buoncompagni A; Gattorno M; Perfumo F
J Nephrol; 2002; 15(2):123-9. PubMed ID: 12018627
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
35. Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide.
Ioannidis JP; Boki KA; Katsorida ME; Drosos AA; Skopouli FN; Boletis JN; Moutsopoulos HM
Kidney Int; 2000 Jan; 57(1):258-64. PubMed ID: 10620207
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of proliferative lupus nephritis with leflunomide and steroid: a prospective multi-center controlled clinical trial].
Cui TG; Hou FF; Ni ZH; Chen XM; Zhang FS; Zhu TY; Zhao XZ; Bao CD; Zhao MH; Wang GB; Qian JQ; Cai GY; Li YN; Lu FM; Mei CL; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):672-6. PubMed ID: 16202258
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics and outcomes of male lupus nephritis in China.
Wang YF; Xu YX; Tan Y; Yu F; Zhao MH
Lupus; 2012 Nov; 21(13):1472-81. PubMed ID: 22898536
[TBL] [Abstract][Full Text] [Related]
39. Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis.
Yan DC; Chou CC; Tsai MJ; Chiang BL; Tsau YK; Hsieh KH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(3):203-9. PubMed ID: 7618472
[TBL] [Abstract][Full Text] [Related]
40. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
